Bidda Sovereign Intelligence · 10,090 Verified Nodes · 39 Sovereign Pillars

Regulation (EU) No 536/2014 of the European Parliament and of the Council on clinical trials on medicinal products for human use - Article 44: Assessment by Member States

This article requires Member States to cooperate in assessing safety information received from the Agency and to involve responsible ethics committees in…

What Regulation (EU) No 536/2014 of the European Parliament and of the Council on clinical trials on medicinal products for human use - Article 44: Assessment by Member States requires

This article requires Member States to cooperate in assessing safety information received from the Agency and to involve responsible ethics committees in this assessment where mandated by national law.

Pillar: Biotech & Genomics · Authority: European Parliament and Council of the European Union · Version: 1.0.0 · Last updated:

Primary source: https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:32014R0536

SHA-256 integrity: 4d780e57a305fc3427af6fb384624c7bbfa1ffb4e6be6f677a4aae748278af2e

Primary Citations — 5 traced to source

  • Article 44(1): The Agency shall, by electronic means, forward to the Member States concerned the information reported in accordance with Article 42 and 43.
  • Article 44(2): Member States shall cooperate in assessing the information reported in accordance with Articles 42 and 43.

+ 3 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.

Access

⚠ Important: Human Verification Required

Bidda compliance nodes are reference intelligence, not legal advice. Every node must be reviewed by a qualified compliance professional or legal counsel before implementation in any enterprise workflow, regulated system, or compliance programme. See bidda.com/disclaimer for full terms.